CRNX Crinetics Pharmaceuticals, Inc. Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
17:25
Aug 10
Aug 10
Highlights past successful biotech valuation calls.
Author lists numerous biotech and pharma tickers as past successful valuation calls, offering no current directional view.
LOW
11:52
Jul 28
Jul 28
Goldman Sachs upgrades CIB to Buy, KeyBanc upgrades FLY to Overweight.
Goldman Sachs upgrades CIB to Buy, KeyBanc upgrades FLY to Overweight, and multiple other analyst upgrades and downgrades are reported across a wide range of stocks with specific price target changes.
05:59
Jul 27
Jul 27
Author highlights Affinity's golden run in biotech and their top 5 FBRX holding post-APGE.
Author highlights Affinity's golden run in biotech and their top 5 FBRX holding post-APGE acquisition, celebrating broad sector gains without explicit forward calls on most names.
LOW
22:02
Jul 23
Jul 23
Author argues that ABVX's hiring activity before a potential buyout mirrors CRNX's precedent.
Author argues that ABVX's hiring activity before a potential buyout mirrors CRNX's precedent, but does not state a personal position or forward call.
LOW
23:23
Jul 21
Jul 21
The tweet details the merger negotiation timeline between Vertex and Crinetics without.
The tweet details the merger negotiation timeline between Vertex and Crinetics without expressing a personal position or forward-looking trade call.
LOW
12:15
Jul 07
Jul 07
Premarket movers report shows mixed Magnificent Seven performance.
Premarket movers report shows mixed Magnificent Seven performance, chipmaker declines on Samsung earnings miss, Broadcom downgraded, Cloudflare upgraded, Crinetics surges on acquisition, Fiserv rises on deal talks, and Plug Power climbs on hydrogen order.
12:15
Jul 07
Jul 07
Broadcom, Crinetics, Fiserv, Nvidia, and Plug Power are highlighted as stocks drawing Wall.
Broadcom, Crinetics, Fiserv, Nvidia, and Plug Power are highlighted as stocks drawing Wall Street's attention before the market open.
11:46
Jul 07
Jul 07
Pre-market movers include Samsung Electronics falling on preliminary Q2 figures.
Pre-market movers include Samsung Electronics falling on preliminary Q2 figures, Nvidia down on DeepSeek's AI chip development, Fiserv up on acquisition talks, Rivian down on share offering, Crinetics up on Vertex acquisition, and First Solar up on Deutsche Bank upgrade.
01:44
Jul 07
Jul 07
Vertex Pharmaceuticals is reportedly acquiring Crinetics Pharmaceuticals for $10 billion.
Vertex Pharmaceuticals is reportedly acquiring Crinetics Pharmaceuticals for $10 billion, a factual M&A announcement with no author position or directional call.
LOW
20:09
Jul 06
Jul 06
Author reflects on selling CRNX too soon before its Vertex acquisition, praises XBI strength.
Author reflects on selling CRNX too soon before its Vertex acquisition, praises XBI strength, and maintains unchanged ABVX and NKTR positions while planning new long ideas and a potential short book.
LOW
20:08
Jul 06
Jul 06
The author congratulates CRNX longs on a premium deal and highlights Vertex and the biotech ETF.
The author congratulates CRNX longs on a premium deal and highlights Vertex and the biotech ETF as part of a broader bullish market observation, not a personal position.
LOW
22:58
May 17
May 17
"Checkpoint Capital opened new positions in CRNX, SEPN, TRVI in Q1 2026.
"Checkpoint Capital opened new positions in CRNX, SEPN, TRVI in Q1 2026. Fund disclosure, no speaker thesis."
HIGH
About CRNX Analyst Coverage
Buzzberg tracks CRNX (Crinetics Pharmaceuticals, Inc.) across 7 sources. 0 bullish vs 0 bearish calls from 7 analysts. Sentiment: evenly split. 12 total trade ideas tracked. Latest voices: seedy19tron, DeItaone, A May MD.